UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date: March 22, 2018
Form: S-3
CIK: 0000109657
Company Name: GT Biopharma, Inc.
File Number: 333-223348